CN116083288B - Leuconostoc mesenteroides producing 2,3-dihydro-2,2,6-trimethylbenzaldehyde and its application - Google Patents
Leuconostoc mesenteroides producing 2,3-dihydro-2,2,6-trimethylbenzaldehyde and its application Download PDFInfo
- Publication number
- CN116083288B CN116083288B CN202211415070.4A CN202211415070A CN116083288B CN 116083288 B CN116083288 B CN 116083288B CN 202211415070 A CN202211415070 A CN 202211415070A CN 116083288 B CN116083288 B CN 116083288B
- Authority
- CN
- China
- Prior art keywords
- strain
- dihydro
- trimethylbenzaldehyde
- leuconostoc mesenteroides
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000192130 Leuconostoc mesenteroides Species 0.000 title claims abstract description 47
- SGAWOGXMMPSZPB-UHFFFAOYSA-N safranal Chemical compound CC1=C(C=O)C(C)(C)CC=C1 SGAWOGXMMPSZPB-UHFFFAOYSA-N 0.000 title claims 5
- 238000000855 fermentation Methods 0.000 claims abstract description 17
- 230000004151 fermentation Effects 0.000 claims abstract description 17
- 238000004321 preservation Methods 0.000 claims abstract description 13
- 230000012010 growth Effects 0.000 claims description 23
- 235000015278 beef Nutrition 0.000 claims description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 5
- 229940099596 manganese sulfate Drugs 0.000 claims description 5
- 239000011702 manganese sulphate Substances 0.000 claims description 5
- 235000007079 manganese sulphate Nutrition 0.000 claims description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 5
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 claims description 5
- 238000003794 Gram staining Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims description 4
- 210000004556 brain Anatomy 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 239000000049 pigment Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000012137 tryptone Substances 0.000 claims description 4
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims 2
- 244000005700 microbiome Species 0.000 abstract description 4
- 239000002609 medium Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 244000124209 Crocus sativus Species 0.000 description 6
- 235000015655 Crocus sativus Nutrition 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 6
- 238000009630 liquid culture Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000013974 saffron Nutrition 0.000 description 6
- 239000004248 saffron Substances 0.000 description 6
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 238000009629 microbiological culture Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000596148 Crocus Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- -1 crocin aldehyde Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000001319 headspace solid-phase micro-extraction Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000002470 solid-phase micro-extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000001393 triammonium citrate Substances 0.000 description 1
- 235000011046 triammonium citrate Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the technical field of biological fermentation, and particularly relates to leuconostoc mesenteroides for producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde and application thereof. Aiming at the technical problem that few 2, 3-dihydro-2, 6-trimethylbenzaldehyde-producing microorganisms are reported, the invention provides a novel leuconostoc mesenteroides (Leuconostoc mesenteroides) strain for producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde. The preservation number of the strain is CGMCC NO.25153. The strain has the content of the produced 2, 3-dihydro-2, 6-trimethyl benzaldehyde of 2.876mg/L in a fermentation medium, has short fermentation period and low cost, and has potential application in producing the 2, 3-dihydro-2, 6-trimethyl benzaldehyde.
Description
Technical Field
The invention belongs to the technical field of biological fermentation, and particularly relates to leuconostoc mesenteroides for producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde and application thereof.
Background
The 2, 3-dihydro-2, 6-trimethylbenzaldehyde is also called crocin, saffron aldehyde, safflower aldehyde and saffron aldehyde, and mainly exists in crocus plants and semi-human equine plants, and can be used as a colorant and a condiment of food preparations, medicines and also can be used for preparing perfumes in crocus, siberia cornflower, chinese green tea and other plants. Researches show that the 2, 3-dihydro-2, 6-trimethyl benzaldehyde has important pharmacological effects in a plurality of systems and tissues, such as cardiovascular protection, anticonvulsant of a central nervous system, relieving clinical symptoms of AD and PD, easing pain, resisting cancer and the like, and the 2, 3-dihydro-2, 6-trimethyl benzaldehyde has obvious inhibition effect and anti-ultraviolet activity on matrix metalloproteinase, shows stronger sun protection, skin aging resistance and other advantages, is focused by students in recent years, and has wide application prospect in medicine, food and cosmetic industries.
Saffron is harsh to growth environment, and is planted in extreme weather, dry and calcized land, and at present Iran is the region with the largest planting area, but has short flowering period and extremely low yield, and under general conditions, only 0.5-0.9kg of saffron is harvested in one mu of land, the annual output in the whole world is only about 250 tons, and the investment cost is high. The 2, 3-dihydro-2, 6-trimethyl benzaldehyde is difficult to synthesize, the content of the existing saffron plant extract is low, the popularization and application of the 2, 3-dihydro-2, 6-trimethyl benzaldehyde are severely limited, and more fresh reports are provided for microorganisms producing 2, 3-dihydro-2, 6-trimethyl benzaldehyde, so that the search of strains capable of producing 2, 3-dihydro-2, 6-trimethyl benzaldehyde is of great significance in improving the yield of 2, 3-dihydro-2, 6-trimethyl benzaldehyde and researching the microbial preparation process.
CN103764818a, although disclosing methods and materials for recombinant production of saffron compounds, as well as nucleotides and polypeptides useful in establishing recombinant pathways for production of compounds such as crocin, crocin aldehyde, crocin acid or crocin ester, recombinant hosts including yeast, escherichia coli (e.coli), plant cells, mammalian cells and insect cells. However, the method only discloses the feasibility of microbial sources of 2, 3-dihydro-2, 6-trimethylbenzaldehyde, and does not consider genetic stability of recombinant microorganisms, expression stability of target genes and stability of continuous production of target products.
Disclosure of Invention
Aiming at the technical problem that few 2, 3-dihydro-2, 6-trimethylbenzaldehyde-producing microorganisms are reported, the invention provides a novel leuconostoc mesenteroides (Leuconostoc mesenteroides) strain for producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde. The preservation number of the strain is CGMCC NO.25153. The preservation time is 2022 and 06 months 21, the preservation center is China general microbiological culture Collection center CGMCC, the address is China national academy of sciences of China, including the Xiyu No. 1 and the Xiyu No. 3 in the Korean area North Star of Beijing, and the postal code is 100101.
Wherein the 16S rDNA sequence of the leuconostoc mesenteroides is shown as SEQ ID NO. 1.
The leuconostoc mesenteroides is characterized in that colony forms are round or bean-shaped, the diameter of the colony is smaller than 1.0mm, the surface is smooth and milky, no pigment is generated, the cell forms are spherical, bean-shaped or short-stalk-shaped, some are arranged in pairs or short chains, do not move and have no spores, and gram staining is positive.
The leuconostoc mesenteroides has the growth conditions of microaerobic nature, good anaerobic culture growth, a growth temperature range of 2-53 ℃, strong acid resistance and a growth optimum pH of 5.5-6.5.
Wherein, the optimal growth temperature of the leuconostoc mesenteroides is 30-40 ℃.
Wherein, the leuconostoc mesenteroides can produce 2, 3-dihydro-2, 6-trimethylbenzaldehyde in a fermentation medium with the yield of 2.876mg/L.
The fermentation medium comprises 16g of glucose, 10g of tryptone, 2.5g of yeast powder, 5g of beef extract, 3.85g of beef brain, 4.9g of beef heart, 0.5g of tween 80,1g of ammonium citrate, 2.5g of sodium chloride, 2.5g of anhydrous sodium acetate, 0.05g of magnesium sulfate, 0.025g of manganese sulfate, 1.25g of disodium hydrogen phosphate and 1g of dipotassium hydrogen phosphate.
The invention also provides application of the leuconostoc mesenteroides in producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde.
The invention has the beneficial effects that the invention separates a new leuconostoc mesenteroides strain with high yield of 2, 3-dihydro-2, 6-trimethylbenzaldehyde from the fermented grains sample of the Lao jiao of Luzhou for the first time. The content of 2, 3-dihydro-2, 6-trimethylbenzaldehyde produced by the strain in a fermentation medium is 2.876mg/L. The method has the advantages of short fermentation period and low cost, provides possibility of preparing the 2, 3-dihydro-2, 6-trimethyl benzaldehyde by a microbiological method, can be used as a research object of recombinant organisms, and has important significance for promoting the industrialized production of the 2, 3-dihydro-2, 6-trimethyl benzaldehyde.
The invention provides a novel leuconostoc mesenteroides strain for producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde, which has a preservation number of CGMCC No.25153. The preservation time is 2022 and 06 months 21, the preservation center is China general microbiological culture Collection center CGMCC, the address is China national academy of sciences of China, including the Xiyu No. 1 and the Xiyu No. 3 in the Korean area North Star of Beijing, and the postal code is 100101. The classification was named Leuconostoc mesenteroides Leuconostoc mesenteroides.
Drawings
FIG. 1 is a mass spectrum of GC-MS molecular fragments of 2, 3-dihydro-2, 6-trimethylbenzaldehyde produced by the strain of the present invention;
FIG. 2 is a mass spectrum of GC-MS molecular fragments of 2, 3-dihydro-2, 6-trimethylbenzaldehyde standard.
Detailed Description
The invention provides a novel leuconostoc mesenteroides (Leuconostoc mesenteroides) strain for producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde. The preservation number of the strain is CGMCC NO.25153. The preservation time is 2022 and 06 months 21, the preservation center is China general microbiological culture Collection center CGMCC, the address is China national academy of sciences of China, including the Xiyu No. 1 and the Xiyu No. 3 in the Korean area North Star of Beijing, and the postal code is 100101.
Wherein the 16S rDNA sequence of the leuconostoc mesenteroides is shown as SEQ ID NO. 1.
SEQ ID NO. 1 16S rDNA sequence of Leuconostoc mesenteroides
TCCTGGCTCACATCAGCTGCGATAGGTAGGGTGCCCCGTTTAGTGTGAGTGGCGAACGGGTGAGTAACACGTGGACAACCTGCCTCAAGGCTGGGGATAACATTTGGAAACAGATGCTAATACCGAATAAAACTTAGTGTCGCATGACACAAAGTTAAAAGGCGCTTCGGCGTCACCTAGAGATGGATCCGCGGTGCATTAGTTAGTTGGTGGGGTAAAGGCCTACCAAGACAATGATGCATAGCCGAGTTGAGAGACTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCTGCAGTAGGGAATCTTCCACAATGGGCGAAAGCCTGATGGAGCAACGCCGCGTGTGTGATGAAGGCTTTCGGGTCGTAAAGCACTGTTGTATGGGAAGAACAGCTAGAATAGGAAATGATTTTAGTTTGACGGTACCATACCAGAAAGGGACGGCTAAATACGTGCCAGCAGCCGCGGTAATACGTATGTCCCGAGCGTTATCCGGATTTATTGGGCGTAAAGCGAGCGCAGACGGTTTATTAAGTCTGATGTGAAAGCCCGGAGCTCAACTCCGGAATGGCATTGGAAACTGGTTAACTTGAGTGCAGTAGAGGTAAGTGGAACTCCATGTGTAGCGGTGGAATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTTACTGGACTGCAACTGACGTTGAGGCTCGAAAGTGTGGGTAGCAAACAGGATTAGATACCCTGGTAGTCCACACCGTAAACGATGAACACTAGGTGTTAGGAGGTTTCCGCCTCTTAGTGCCGAAGCTAACGCATTAAGTGTTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGACCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGTCTTGACATCCTTTGAAGCTTTTAGAGATAGAAGTGTTCTCTTCGGAGACAAAGTGACAGGTGGTGCATGGTCGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATTGTTAGTTGCCAGCATTCAGATGGGCACTCTAGCGAGACTGCCGGTGACAAACCGGAGGAAGGCGGGGACGACGTCAGATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGCGTATACAACGAGTTGCCAACCCGCGAGGGTGAGCTAATCTCTTAAAGTACGTCTCAGTTCGGATTGTAGTCTGCAACTCGACTACATGAAGTCGGAATCGCTAGTAATCGCGGATCAGCACGCCGCGGTGAATACGTTCCCGGTTGATGTACACCCCGCCTCTCACACCATAGGCAAGGTAACCGTAGAGTTTGATCCTGGCTCAGTAAGTCGTAACAAGGTAGCCGTAGAG.
The leuconostoc mesenteroides has the biological characteristics that colony forms are round or bean-shaped, the diameter of the colony is smaller than 1.0mm, the surface is smooth and milky, no pigment is produced, the cell forms are spherical, bean-shaped or short-stalk-shaped, some are arranged in pairs or short chains, no movement and no spore are produced, and gram staining is positive.
The leuconostoc mesenteroides has good growth conditions of microaerobic anaerobic culture, the growth temperature ranges from 2 ℃ to 53 ℃, the optimal growth temperature ranges from 30 ℃ to 40 ℃, the acid resistance is strong, and the optimal growth pH is 5.5 to 6.5.
The invention also provides a screening and identifying method of the leuconostoc mesenteroides, which comprises the following steps of scattering, separating, marking, purifying and preserving strain of a luzhou Laojiao fermented grain sample, and obtaining the leuconostoc mesenteroides producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde by taking the capability of producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde as a screening standard.
The fermented grain sample is diluted by taking suspension after being scattered by shaking, and a plurality of gradient dilutions are coated on a solid culture medium flat plate so as to perform anaerobic culture. The micro-aerobic bacteria can grow well in an anaerobic state, and anaerobic culture is selected during screening.
Wherein, single colonies with different colony morphologies are picked on a plate on which colonies are grown, and all single colonies are purified by secondary streaking.
Wherein each strain after purification is subjected to stationary culture in MRS liquid medium in the form of single colony.
The method comprises the steps of respectively fermenting different strains to obtain fermentation bacteria liquid, extracting and enriching a target compound by using a headspace solid-phase microextraction method, and then performing chromatographic detection analysis by using GC-MS (gas chromatography-mass spectrometry) to screen and obtain the leuconostoc mesenteroides with high yield of 2, 3-dihydro-2, 6-trimethyl benzaldehyde by comparing the content of volatile substances.
The invention also provides application of the leuconostoc mesenteroides in producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde.
Specifically, the application is that leuconostoc mesenteroides is subjected to static culture in a fermentation medium at 37 ℃ for 2 days, the pH value is 6.0, and the inoculation amount of the leuconostoc mesenteroides is 2% (. Times.10 7 cfu/mL).
More specifically, the fermentation medium comprises 16g of glucose, 10g of tryptone, 2.5g of yeast powder, 5g of beef extract, 3.85g of beef brain, 4.9g of beef heart, 0.5g of tween 80,1g of ammonium citrate, 2.5g of sodium chloride, 2.5g of anhydrous sodium acetate, 0.05g of magnesium sulfate, 0.025g of manganese sulfate, 1.25g of disodium hydrogen phosphate and 1g of dipotassium hydrogen phosphate per liter of medium.
By adopting the fermentation process, the content of 2, 3-dihydro-2, 6-trimethylbenzaldehyde produced by the strain is 2.876mg/L.
The scheme of the present invention will be explained below with reference to examples. It will be appreciated by those skilled in the art that the following examples are illustrative of the present invention and should not be construed as limiting the scope of the invention. The examples are not to be construed as limiting the specific techniques or conditions described in the literature in this field or as per the specifications of the product. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
The medium formulation referred to in the examples:
MRS liquid culture medium comprises 20g/L glucose, 10g/L peptone, 4g/L yeast powder, 5g/L beef extract powder, 1g/L Tween 80, 2g/L triammonium citrate, 5g/L sodium acetate, 0.2g/L magnesium sulfate, 0.05g/L manganese sulfate, 1g/L dipotassium hydrogen phosphate, pH6.0 and high-pressure steam sterilization at 115 ℃ for 20 minutes.
MRS solid Medium 15g/L agar was added on the basis of MRS liquid Medium and autoclaved at 115℃for 20 minutes.
The fermentation medium comprises 16g/L of glucose, 10g/L of tryptone, 2.5g/L of yeast powder, 5g/L of beef extract, 3.85g/L of beef brain, 4.9g/L of beef heart, 0.5g/L of tween 80, 1g/L of ammonium citrate, 2.5g/L of sodium chloride, 2.5g/L of anhydrous sodium acetate, 0.05g/L of magnesium sulfate, 0.025g/L of manganese sulfate, 1.25g/L of disodium hydrogen phosphate, 1g/L of dipotassium hydrogen phosphate and sterilizing by high-pressure steam at the pH of 6.0,115 ℃ for 20 minutes.
EXAMPLE 1 isolation and purification of strains
(1) The separation method comprises taking 20g of fermented grains of Luzhou Laojiao, placing into a conical flask containing 180mL sterile distilled water, shaking with a constant temperature shaking table for 10min, and thoroughly dispersing and mixing. Taking 1mL of sample suspension, diluting to 10 -2~10-7 by adopting a double-ratio dilution method, sucking 100 mu L of the diluted solution of each gradient, uniformly coating the diluted solution on an MRS solid culture medium plate, preparing two plates in parallel, inverting, culturing for 36-48h under anaerobic condition at 37 ℃ and observing in time.
(2) And (3) streaking and purifying, namely taking out a plate with the colonies, picking single colonies with different colony morphologies, and streaking for the second time until all the single colonies are purified.
(3) And (3) preserving the strain, namely picking single colonies of each strain after purification into a 5mLMRS liquid culture medium, standing and culturing for 20-24 hours at 37 ℃ under anaerobic condition, sucking 1mL of bacterial liquid into a bacteria-preserving tube, adding 0.5mL of 60% sterile glycerol solution, re-suspending, and preserving at-80 ℃.
Example 2 detection of 2, 3-dihydro-2, 6-trimethylbenzaldehyde producing ability
(1) Preparing a bacterial liquid to be tested:
after the glycerol preservation tube of the strain obtained by screening is dissolved, the glycerol preservation tube is respectively inoculated into an MRS liquid culture medium, and is subjected to static culture for 24 hours at 37 ℃, and after three generations of activation, the glycerol preservation tube is inoculated into a 50mLMRS liquid culture medium according to the inoculum size of 2% (volume ratio) for culture for 24 hours, so that the bacterial liquid to be detected is obtained.
(2) HS-SPME/GC-MS method for detecting 2, 3-dihydro-2, 6-trimethylbenzaldehyde:
Taking supernatant, adding the supernatant into a headspace bottle, adding saturated NaCl solution, taking 0.822mg/ml of 2-octanol as an internal standard substance, carrying out heat preservation and balance on the prepared sample at 60 ℃ for 5min, extracting the sample at 60 ℃ for 50min by using a 50/30 mu mDVB/CAR/PDMS extraction head, and desorbing the sample at 250 ℃ for 5min at a GC sample inlet after the extraction is finished. And (5) matching the compound search result with an NIST standard spectrum library, and confirming that the similarity reaches more than 80% as a target compound. The culture solution without bacteria is used as a blank control group to calculate the content of each volatile substance.
GC-MS detection chromatographic conditions:
The gas chromatography conditions are HP-INNOWAX chromatographic column (60 m×0.25mm×0.25 μm), heating program, the initial temperature is 40 ℃, the temperature is kept for 5min, the temperature is raised to 100 ℃ at 4 ℃ per min, the temperature is raised to 230 ℃ at 6 ℃ per min, the temperature is kept for 10min, the carrier gas is high-purity helium (1.0 mL/min), and the temperature of the sample inlet is 250 ℃ without split flow.
The mass spectrum conditions comprise an electron ionization source, electron energy of 70eV, electron multiplier voltage of 350V, ion source temperature of 230 ℃, transmission line temperature of 250 ℃ and mass range of 40-450 m/z.
By the detection method, a lactobacillus with stronger capability of producing 2, 3-dihydro-2, 6-trimethylbenzaldehyde is screened from the separated strain, and the strain is selected for further research.
Example 3 molecular characterization of strains
And (3) amplifying and culturing the target strain, taking fresh bacterial liquid in the logarithmic growth phase, centrifugally collecting bacterial cells, and extracting genome DNA by using a bacterial genome extraction kit. The full-length sequence of the 16S rDNA is amplified by adopting a lactobacillus universal primer 27F/1541R, and the method is concretely as follows:
SEQ ID NO:2:27F(5′-AGAGTTTGATCCTGGCTCAG-3′)
SEQ ID NO:3:1541R(5′-AAGGAGGTGATCCAGCC-3′)
① Reaction system (50 μl)
② Reaction procedure
The PCR reaction of the "denaturation-annealing-extension" was performed 35 times in the above procedure, and the PCR product was checked by electrophoresis on a 1.0% agarose gel at a voltage of about 11V/cm for 20min.
The purification of PCR products was performed as described in the Shanghai Biotechnology Co small amount of gel recovery PCR product purification kit, and sequencing was performed by Shanghai Biotechnology Co.
The gene sequence of the 16S rDNA fragment obtained by sequencing is compared by BLAST of NCBI, the strain species information is determined, the strain species information is identified as leuconostoc mesenteroides (Leuconostoc mesenteroides), and the leuconostoc mesenteroides is preserved in the preservation center of China general microbiological culture collection center (CGMCC) in the year 2022 and the month 21, and the preservation number is CGMCC NO.25153. And is designated Leuconostoc mesenteroides zqw121,121.
Example 4 physiological and Biochemical characteristics of Leuconostoc mesenteroides zqw121,121
Leuconostoc mesenteroides zqw121,121 was inoculated to MRS solid medium, and after 2 days of stationary culture at 37 ℃, the colony and cell morphology of the strain were observed.
Measuring temperature suitable for growth, namely inoculating Leuconostoc mesenteroides zqw121 in logarithmic growth phase into MRS liquid culture medium according to 2% of inoculum size, and respectively culturing at 2, 10, 15, 20, 30, 40, 45 and 53 ℃ for 18 hours to measure the OD 600 value of the bacterial liquid;
the pH tolerance measurement comprises adjusting MRS liquid culture medium pH to 3.0, 5.0, 5.5, 6.0, 6.5 and 7.0 respectively with 2M hydrochloric acid and 1M sodium hydroxide, inoculating Leuconostoc mesenteroides zqw121 in logarithmic phase, mixing completely and uniformly, culturing at 37deg.C for 18 hr, and measuring bacterial liquid OD 600;
the effect of oxygen on bacterial growth was determined by submerged agar method by inoculating Leuconostoc mesenteroides zqw, 121 in MRS solid medium tube, culturing at 37deg.C for 2 days, and judging the oxygen demand of various bacteria according to the growth position of strain in tube medium.
Experimental results show that the leuconostoc mesenteroides zqw121,121 has the biological characteristics that colony forms are round or bean-shaped, the diameter of the colony is smaller than 1.0mm, the surface is smooth and milky, no pigment is produced, the cell forms are spherical, bean-shaped or short-stalk-shaped, some are paired or arranged in short chain, do not move and have no spores, and gram staining is positive.
The Leuconostoc mesenteroides zqw121 has the growth conditions of microaerobic nature, good anaerobic culture growth, the growth temperature range of 2-53 ℃, the optimal growth temperature of 30-40 ℃ and the optimal growth pH of 5.5-6.5.
EXAMPLE 5 fermentation culture of Leuconostoc mesenteroides zqw121
After the obtained leuconostoc mesenteroides zqw-121 glycerol storage tube was dissolved, the obtained leuconostoc mesenteroides was inoculated into 10mL of a liquid-filled MRS liquid medium according to an inoculum size of 5%, and after 24 hours of stationary culture at 37 ℃, the obtained leuconostoc mesenteroides was inoculated into 400mL of a fermentation medium according to an inoculum size of 2%, and then stationary culture was carried out for 2 days at 37 ℃. The detection method was the same as the volatile component measurement method in example 2. After continuous culture of Leuconostoc mesenteroides for 2 days, the yield of the produced 2, 3-dihydro-2, 6-trimethylbenzaldehyde can reach 2.876mg/L.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211415070.4A CN116083288B (en) | 2022-11-11 | 2022-11-11 | Leuconostoc mesenteroides producing 2,3-dihydro-2,2,6-trimethylbenzaldehyde and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211415070.4A CN116083288B (en) | 2022-11-11 | 2022-11-11 | Leuconostoc mesenteroides producing 2,3-dihydro-2,2,6-trimethylbenzaldehyde and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116083288A CN116083288A (en) | 2023-05-09 |
CN116083288B true CN116083288B (en) | 2025-02-18 |
Family
ID=86187619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211415070.4A Active CN116083288B (en) | 2022-11-11 | 2022-11-11 | Leuconostoc mesenteroides producing 2,3-dihydro-2,2,6-trimethylbenzaldehyde and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116083288B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103764818A (en) * | 2011-08-08 | 2014-04-30 | 埃沃尔瓦公司 | Methods and materials for recombinant production of saffron compounds |
KR101809447B1 (en) * | 2016-11-25 | 2017-12-15 | 대상 주식회사 | Leuconostoc mesenteroides DRC1506 and Use thereof |
-
2022
- 2022-11-11 CN CN202211415070.4A patent/CN116083288B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103764818A (en) * | 2011-08-08 | 2014-04-30 | 埃沃尔瓦公司 | Methods and materials for recombinant production of saffron compounds |
KR101809447B1 (en) * | 2016-11-25 | 2017-12-15 | 대상 주식회사 | Leuconostoc mesenteroides DRC1506 and Use thereof |
Also Published As
Publication number | Publication date |
---|---|
CN116083288A (en) | 2023-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107629973B (en) | Pichia kudriavzevii strain for producing β -phenethyl alcohol and application thereof | |
CN111218415B (en) | Bacillus licheniformis for high-yield tetramethylpyrazine and isolated culture method and application thereof | |
CN106754508B (en) | A strain of Bacillus subtilis and its application in soy sauce fermentation and aroma enhancement | |
CN103695341B (en) | A kind of algin catenase secreted by marine bacteria and preparation method thereof | |
CN105602863A (en) | Bacillus subtilis strain for high yield of lipopeptide antibiotic and poly-gamma-glutamic acid | |
CN110093285B (en) | Acid-resistant lactobacillus fermentum and application thereof | |
CN110042072B (en) | Aflatoxin B degradation1And application thereof | |
CN110484479A (en) | One plant of Paracoccus kondratievae and its application in degradation of white spirit nocuousness ester | |
CN112746036A (en) | Streptomyces and method for producing pseudouridine by fermenting same | |
WO2022262874A1 (en) | Burkholderia sp. and method for producing fr901464 by fermentation thereof | |
CN114196586B (en) | Enterococcus mundtii and application thereof in fermenting Chinese herbal medicines | |
CN109988721B (en) | A strain of yeast luteria that can increase the aroma of sauces | |
CN102643756B (en) | Endophytic fungus for improving content of glycyrrhetinic acid by fermenting liquorice | |
CN114032187B (en) | Kluyveromyces marxianus strain from Tibetan yoghurt and application thereof | |
CN116083288B (en) | Leuconostoc mesenteroides producing 2,3-dihydro-2,2,6-trimethylbenzaldehyde and its application | |
CN112877257A (en) | Bacillus licheniformis and application thereof | |
CN117070382A (en) | Strain for high-yield tetra-acetyl phytosphingosine and application thereof | |
CN115820474B (en) | Gallinarum Enterococcus producing 3,4-dimethylbenzaldehyde and its application | |
WO2023016387A1 (en) | Bacillus amyloliquefaciens and use thereof in preparation of 1-deoxynojirimycin | |
CN117343871A (en) | Acinetobacter baumannii, esterified liquid and application thereof in yellow water treatment | |
CN109735473B (en) | Preparation of water-soluble curcumin by fermentation | |
CN109401998B (en) | A strain of Lactobacillus Mindena degrading biogenic amines and its application | |
CN118667707B (en) | A strain of Enterococcus faecalis producing pyrazine compounds and its application | |
CN115717114B (en) | Thai enterococcus capable of producing multiple aldehyde aroma substances and application thereof | |
CN116286513B (en) | Lactobacillus johnsonii FR-1012 and method for industrially producing gamma-aminobutyric acid by same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |